Abstract
We investigated the air change rate (ACR) using the tracer gas method in five areas where the risk of aerosol infection was assumed to be high for an outbreak of an infection among 59 people in a nursing home in Miyagi Prefecture, Japan. The ACRs at the time of the outbreak were estimated to be 4.35, 2.42, 2.04, 4.96, and 6.26 per hour in the general bathroom, special bathroom, shared room, private room, and day room, respectively. In general bathrooms, special bathrooms, shared rooms, and private rooms, the ACR greatly increased by 1.48□5.74 times by opening windows. Because the private rooms, where the initial infected patients were thought to have been, were spatially connected to the common recreational day room, the transfer of aerosols from private rooms to the day room may have been the origin of the mass infection. We reproduced the downwind contamination situation using thermo-fluid simulations and found that infectious aerosols could reach the day room in approximately one minute through the corridor. In elderly care facilities, open architectural spaces are advocated to realize a Quality of Life (QºL) and monitor residents; however, management is required to reduce the downwind infection risk from aerosols and ACR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JSPS KAKENHI Grant No. 21K19820 and KDDI foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee on Experiments on Human Subjects in the Corresponding author's institution (the University of Electro-Communications, Tokyo, Japan). The approval number is 21005.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data availability statement The data that support the findings of this study are available from the corresponding author, Y.I., upon reasonable request.
Conflict of interest statement The authors have no potential conflicts of interest to declare.
Ethics approval statement This study was approved by the Ethics Committee on Experiments on Human Subjects in the Corresponding author’s institution. The approval number is 21005.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos